C1orf133 was known as a kind of ncRNA SERTAD4-AS1, and also its expression was first identified in our study to be correlated with prognosis of HCC and even associated with TACE treatment response. This evidence concerns the gene SERTAD4-AS1 and hepatocellular carcinoma.